[1]
Rehman, E. , Hasnain Ali Shah, S. , Nabi, M. , Subhan, Z. , Zaman, S., Naeem, N. , Khurrum, D.-E.-J. and Ullah, I. 2022. High Risk of Cardiovascular Events in Patients, Biosynthesis of Aspirin-Resistant Thromboxane And The Risk Of Stroke, Myocardial Infarction Or Death: Biosynthesis of Aspirin-Resistant Thromboxane & Risk of Stroke. Pakistan BioMedical Journal. 5, 6 (Jun. 2022), 213–218. DOI:https://doi.org/10.54393/pbmj.v5i6.583.